Although the difference between groups was not statistically significant, patients with non-metastatic neoplasms had 65% lower uPA values than those with metastasis, suggesting that aggressive neoplasms can secrete higher uPA levels into the circulation. This evidence concerns the gene PLAU and metastatic neoplasm.